Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2023
Get in-depth analysis of how COVID-19 is impacting the Contract Research Organization Services (CROs) Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Contract Research Organization Services (CROs) Market
Request Now[260 Pages Report] Contract research organizations (CROs) offer testing and consulting services for every stage of the drug R&D process for commercial manufacturers such as pharmaceutical and biopharmaceutical companies and medical device firms. The CRO services market is valued at USD 36.27 Billion in 2017 and projected to reach to USD 56.34 Billion by 2023, at a CAGR of 7.6%. Base year considered for the report is 2017 and forecast period includes 20182023. Growing R&D expenditures, increased outsourcing of R&D activities, and increasing number of clinical trials are the major factors driving the growth of the market.
Market Dynamics
Increased outsourcing of R&D activities
According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the number of new chemical or biological entities launched by pharmaceutical and biopharmaceutical companies in the global market increased to 233 during 20122016 compared with 148 during 20022006, a decade earlier.
Globally, pharmaceutical and biopharmaceutical companies are primarily focusing on the development of new drugs for various unmet therapeutic conditions. Over the last decade, pharmaceutical and biopharmaceutical companies have increasingly outsourced most of their R&D activities to bring new products to the market cost-effectively. It is widely known that the global pharmaceutical and biopharmaceutical industry is currently undergoing a dynamic change due to the patent cliff. In recent years, due to the enormous pressure to contain fixed costs, outsourcing has evolved as a strategic alternative for pharmaceutical and biopharmaceutical companies due to lack of in-house resources required for new product development and the need for cost and time savings.
Various testing services (clinical and laboratory) are required throughout the development phase of any drug substance. Outsourcing of analytical and clinical services helps pharmaceutical and biopharmaceutical companies to mitigate risks by avoiding large investments in purchasing equipment and maintaining manpower, especially when development efforts are in the early stages. It also helps pharmaceutical companies focus on their core competencies. Thus, the development of new drug molecules is expected to propel the demand for CRO services.
Rising demand for specialized testing services
Traditionally, pharmaceutical, biopharmaceutical, and medical device companies outsourced only late-phase drug development and routine processes to analytical testing service providers and conducted the early-phase method development projects and problem-solving activities in-house. However, in recent years, they are increasingly outsourcing testing services much earlier in the product development cycle, to focus on their core strengths. Pharmaceutical companies choose to outsource services to CROs majorly to gain access to innovative technologies that accelerate the development of the compound through the product pipeline. For instance, companies like Pfizer, Merck, and Roche have reduced their in-house testing services to fuel their R&D pipelines in order to meet the growing demand for new drug molecules for various therapeutic areas.
Currently, many pharmaceutical and biopharmaceutical companies are focusing on building a diverse product portfolio and developing new small and large molecules. Combination products, delivery devices, and reformulated or re-engineered drugs are being developed by companies in order to cater to the unmet needs.
Pharmaceutical industries are focusing on various specialized testing services such as Liquid chromatography-mass spectrometry (LC/MS), RNA sequencing, gene expression analysis, wet chemistry analysis of compendial raw materials, trace metal analysis with Inductively Coupled Mass Spectrometry (ICP-MS), and various others. These tests require high-end equipment and skilled professionals. In order to save the cost of equipment and labor, pharmaceutical and biopharmaceutical companies prefer to outsource these specialized testing services to CROs.
Shortage of skilled professionals
The global pharmaceutical, biotechnology, and medical device R&D outsourcing industry is constantly evolving. Highly skilled professionals have to keep pace with the continuing changes in pharmaceutical and medical device R&D technologies and methodologies. Skilled professionals also have to provide quality services and comply with the good laboratory practices. CROs face challenges in attracting and retaining highly skilled professionals as they compete with pharmaceutical, biotechnology, medical device, and academic and research institutions for qualified and experienced scientists. To compete effectively, companies have to offer higher compensations and other benefits; this may affect the finances and results of operations of players, especially small-scale analytical testing providers. This shortage of skilled professionals may hamper the adoption of new technologies and methodologies, and inhibit the growth of the CRO services market in the coming years.
Objectives of the Study
- To define, describe, segment and forecast the global market by type, therapeutic area, end user, and region
- To forecast the size of the market with respect to the five key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the major factors influencing the growth of the contract research organization services market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the contract research organization services market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players in the global market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as mergers and acquisitions; agreements, partnerships, and collaborations; service launches; and expansions of key players in the global market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of contract research organization services market. The breakdown of profiles of primary research participants is shown in the figure below:
IQVIA (US), LabCorp (US), Syneos Health (US), PAREXEL (US), PPD (US), ICON plc (Ireland), PRA Health Sciences (US), and Charles River (US) are some of the key players in the global CRO services market.
Target Audience
- Pharmaceutical and biopharmaceutical companies
- Contract research organizations (CROs)
- Medical device manufacturing companies
- Academic and research institutes
- Government associations
- Market research and consulting Firms
- Venture capitalists and investors
Scope of the Report:
In this report, the market has been segmented into the following segments and subsegments:
CRO Services Market, by Type
- Early Phase Development Services
- Discovery Studies
- Chemistry, Manufacturing & Control
- Preclinical Services
- Pharmacokinetics/Pharmacodynamics (PK/PD)
- Toxicology Testing
- Others
- Clinic Research Services
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Bioanalytical Testing
- Analytical Testing
- Physical Characterization
- Stability Testing
- Batch Release Testing
- Raw Material Testing
- Other Analytical Testing
- Consulting Services
CRO Services Market, by Therapeutic Area
- Oncology
- CNS Disorders
- Infectious Diseases
- Cardiovascular Diseases
- Immunological Disorders
- Respiratory Disorders
- Diabetes
- Other Therapeutic Areas
CRO Services Market, by End User
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
CRO Services Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East and Africa
Available Customization:
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific market into South Korea, Australia, New Zealand, and others
- Further breakdown of the Rest of Europe market into Belgium, Russia, Netherlands, Switzerland, and others
- Further breakdown of the Rest of Latin America market into Brazil, Argentina, and Mexico
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
The global contract research organization services market is projected to reach USD 56.34 Billion by 2023 from USD 39.13 Billion in 2018, at a CAGR of 7.6%. Market growth can be attributed to the growing R&D expenditure, increased outsourcing of R&D activities, and increasing number of clinical trials.
The report analyzes the global market, by type, therapeutica area, end user, and region. Based on type, clinical research services accounted for the largest share of global CRO services market in 2017. This can be attributed to rapid growth in the geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing development of new drugs, and growing acceptance of evidence-based medicine for various therapeutic areas.
Based on therapeutic area, oncology accounted for the largest share of the global market in 2017. The large share of this segment can be attributed to the increasing number of clinical trials and rising prevalence of cancer worldwide.
The global market, by end user, is segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes. In 2017, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the contract research organization services market. The large share of this segment can be attributed to the increased outsourcing of early phase development services and clinical and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate the process and product.
Geographically, the global market has been segmented into five major regional segments North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the market in 2017, followed by Europe and Asia Pacific. North Americas leading position in contract research organization services market is primarily attributed to the high-quality standards in the pharmaceutical industry, rapid growth in its Biosimilars and biologics market, and increase in clinical trial activity.
The global pharmaceutical, biotechnology, and medical device R&D outsourcing industry is constantly evolving. Highly skilled professionals have to keep pace with the continuing changes in pharmaceutical and medical device R&D technologies and methodologies. CROs face challenges in attracting and retaining highly skilled professionals as they compete with pharmaceutical, biotechnology, medical device, and academic and research institutions for qualified and experienced scientists. To compete effectively, companies have to offer higher compensations and other benefits; this may affect the finances and results of operations of players, especially small-scale analytical testing providers. This shortage of skilled professionals may hamper the adoption of new technologies and methodologies, and inhibit the growth of the market in the coming years.
The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), PRA Health Sciences (US), PPD (US), ICON plc (Ireland), Syneos Health (US), Charles River (US), WuXi PharmaTech (China), SGS (Switzerland), Envigo (UK), and MPI Research (US).
IQVIA dominates the market, led by its strong performance in the biopharmaceutical services industry with wide geographical coverage. The companys foothold in the market is primarily attributed to various factors such as strong technical and service capabilities, good client relationships, diversified service offerings, and its ability to expand the penetration of its offerings to a broad range. The company has registered significant growth in the biopharmaceutical services industry, and has a presence in all major markets, including the US, Japan, Germany, France, Spain, and Italy, in addition to Brazil, Russia, India, and China (BRIC countries). To increase its geographic presence and customer base, the company focused on expansion as a key growth strategy. Over the past three years, the company has made three major expansions. Moreover, IQVIA also focused on mergers and acquisitions to enhance and strengthen its position in the global contract research organization services market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 32)
4 Premium Insights (Page No. - 35)
4.1 Market Overview
4.2 Asia Pacific: Market, By Type and Country
4.3 Market: Geographic Growth Opportunities
4.4 Market: Geographic Mix
4.5 Market: Developing vs Developed Countries
5 Market Overview (Page No. - 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing R&D Expenditure
5.2.1.2 Increased Outsourcing of R&D Activities
5.2.1.3 Increasing Number of Clinical Trials
5.2.2 Opportunities
5.2.2.1 Growth in the Biosimilars and Biologics Markets
5.2.2.2 Rising Demand for Specialized Testing Services
5.2.2.3 Emerging Asian Markets
5.2.3 Challenges
5.2.3.1 Intense Competition in the Market
5.2.3.2 Shortage of Skilled Professionals
5.3 Industry Trends
5.3.1 Growing Consolidation in the CRO Industry
5.3.2 Increasing Outsourcing of Clinical Trials to Emerging Markets
5.3.3 Adoption of New Technologies
6 CRO Services Market, By Type (Page No. - 52)
6.1 Introduction
6.2 Clinical Research Services
6.2.1 Phase I Clinical Research Services
6.2.2 Phase Ii Clinical Research Services
6.2.3 Phase Iii Clinical Research Services
6.2.4 Phase Iv Clinical Research Services
6.3 Early-Phase Development Services
6.3.1 Discovery Studies
6.3.2 Chemistry, Manufacturing, & Control (CMC)
6.3.3 Preclinical Services
6.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
6.3.3.2 Toxicology Testing Services
6.3.3.3 Other Preclinical Services
6.4 Laboratory Services
6.4.1 Bioanalytical Testing Services
6.4.2 Analytical Testing Services
6.4.2.1 Physical Characterization
6.4.2.2 Raw Material Testing
6.4.2.3 Batch-Release Testing
6.4.2.4 Stability Testing
6.4.2.5 Other Analytical Testing Services
6.5 Consulting Services
7 Global CRO Services Market, By Therapeutic Area (Page No. - 85)
7.1 Introduction
7.2 Oncology
7.3 Infectious Diseases
7.4 Central Nervous System (CNS) Disorders
7.5 Immunological Disorders
7.6 Cardiovascular Diseases
7.7 Respiratory Disorders
7.8 Diabetes
7.9 Other Therapeutic Areas
8 CRO Services Market, By End User (Page No. - 104)
8.1 Introduction
8.2 Pharmaceutical & Biopharmaceutical Companies
8.3 Medical Device Companies
8.4 Academic Institutes
9 CRO Services Market, By Region (Page No. - 111)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape (Page No. - 190)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Agreements, Collaborations, Joint Ventures, and Partnerships (2014-2017)
10.3.2 Service Launches (2014-2017)
10.3.3 Expansions (2014-2017)
10.3.4 Acquisitions (2014-2017)
11 Company Profiles (Page No. - 197)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 IQVIA
11.2 LabCorp
11.3 PAREXEL
11.4 PRA Health Sciences
11.5 PPD
11.6 ICON PLC
11.7 Syneos Health
11.8 WuXi Pharmatech
11.9 Charles River
11.10 MeDPAce Holdings
11.11 SGS
11.12 Envigo
11.13 MPI Research
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 249)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (220 Tables)
Table 1 Exchange Rates Utilized for the Conversion to USD
Table 2 R&D Expenditure & Percentage Change, By Pharmaceutical Company (20142016)
Table 3 Increased Outsourcing of R&D Activities to Drive Market Growth
Table 4 List of Biological License Application Approvals in the US, 2016
Table 5 Clinical Studies for Biologic & Biosimilar Molecules (2017)
Table 6 Growing Biosimilars and Biologics Markets to Provide Significant Growth Opportunities
Table 7 Intense Competition in the Market is A Major Challenge in the Market
Table 8 Major Mergers and Acquisitions in CRO Industry (2013-2017)
Table 9 Market, By Type, 20162023 (USD Million)
Table 10 Market, By Country, 20162023 (USD Million)
Table 11 Number of Registered and Recruiting Clinical Studies, By Location, 2017
Table 12 Key Clinical Research Services Offered By Prominent Players
Table 13 Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 14 Clinical Research Services Market, By Country, 20162023 (USD Million)
Table 15 Completed Phase Ii Studies for Different Therapeutic Areas
Table 16 Phase I Clinical Research Services Market, By Country, 20162023 (USD Million)
Table 17 Completed Phase Ii Studies for Different Therapeutic Areas
Table 18 Phase Ii Clinical Research Services Market, By Country, 20162023 (USD Million)
Table 19 Completed Phase Iii Studies for Different Therapeutic Areas
Table 20 Phase Iii Clinical Research Services Market, By Country, 20162023 (USD Million)
Table 21 Completed Phase Iv Studies for Different Therapeutic Areas
Table 22 Phase Iv Clinical Research Services Market, By Country, 20162023 (USD Million)
Table 23 Key Early-Phase Development Services Offered By Prominent Players
Table 24 Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 25 Early-Phase Development Services Market, By Country, 20162023 (USD Million)
Table 26 Discovery Studies Market, By Country, 20162023 (USD Million)
Table 27 Chemistry, Manufacturing, & Control Market, By Country, 20162023 (USD Million)
Table 28 Preclinical Services Market, By Type, 20162023 (USD Million)
Table 29 Preclinical Services Market, By Country, 20162023 (USD Million)
Table 30 Pharmacokinetics/Pharmacodynamics Market, By Country, 20162023 (USD Million)
Table 31 Toxicology Testing Services Market, By Country, 20162023 (USD Million)
Table 32 Other Preclinical Services Market, By Country, 20162023 (USD Million)
Table 33 Laboratory Services: Key Services Offered By Prominent Players
Table 34 Laboratory Services Market, By Type, 20162023 (USD Million)
Table 35 Laboratory Services Market, By Country, 20162023 (USD Million)
Table 36 Bioanalytical Testing Services Market, By Country, 20162023 (USD Million)
Table 37 Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 38 Analytical Testing Services Market, By Country, 20162023 (USD Million)
Table 39 Physical Characterization Services Market, By Country, 20162023 (USD Million)
Table 40 Raw Material Testing Services Market, By Country, 20162023 (USD Million)
Table 41 Batch-Release Testing Services Market, By Country, 20162023 (USD Million)
Table 42 Stability Testing Services Market, By Country, 20162023 (USD Million)
Table 43 Other Analytical Testing Services Market, By Country, 20162023 (USD Million)
Table 44 Consulting Services: Key Services Offered By Prominent Players
Table 45 Consulting Services Market, By Country, 20162023 (USD Million)
Table 46 Global Number of Clinical Trials in Different Therapeutic Areas, 2017
Table 47 CRO Services Market, By Therapeutic Area, 20162023 (USD Million)
Table 48 Market for Oncology, By Country, 20162023 (USD Million)
Table 49 List of Pipeline Drugs for Infectious Diseases (2016)
Table 50 Market for Infectious Diseases, By Country, 20162023 (USD Million)
Table 51 List of Pipeline Drugs for CNS Disorders (2016)
Table 52 Market for CNS Disorders, By Country, 20162023 (USD Million)
Table 53 Prevalence of Pid, By Region, 2013 vs 2015
Table 54 List of Pipeline Drugs for Immunological Disorders (2016)
Table 55 Market for Immunological Disorders, By Country, 20162023 (USD Million)
Table 56 List of Pipeline Drugs for Cardiovascular Diseases (2016)
Table 57 Market for Cardiovascular Diseases, By Country, 20162023 (USD Million)
Table 58 List of Pipeline Drugs for Respiratory Disorders (2016)
Table 59 Market for Respiratory Disorders, By Country, 20162023 (USD Million)
Table 60 List of Pipeline Drugs for Diabetes (2016)
Table 61 Market for Diabetes, By Country, 20162023 (USD Million)
Table 62 List of Pipeline Drugs for Other Therapeutic Areas (2016)
Table 63 Market for Other Therapeutic Areas, By Country/Region, 20162023 (USD Million)
Table 64 Market, By End User, 20162023 (USD Million)
Table 65 Number of Biopharmaceutical Drugs in Development Across the Globe, 2016
Table 66 CRO Services Market for Pharmaceutical and Biopharmaceutical Companies, By Country, 20162023 (USD Million)
Table 67 Market for Medical Device Companies, By Country, 20162023 (USD Million)
Table 68 Market for Academic Institutes, By Country, 20162023 (USD Million)
Table 69 Market, By Region, 20162023 (USD Million)
Table 70 North America: CRO Services Market, By Country, 20162023 (USD Million)
Table 71 North America: Market, By Type, 20162023 (USD Million)
Table 72 North America: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 73 North America: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 74 North America: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 75 North America: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 76 North America: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 77 North America: Market, By Therapeutic Area, 20162023 (USD Million)
Table 78 North America: Market, By End User, 20162023 (USD Million)
Table 79 Total Number of Clinical Trials in the US (2017)
Table 80 US: CRO Services Market, By Type, 20162023 (USD Million)
Table 81 US: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 82 US: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 83 US: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 84 US: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 85 US: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 86 US: Market, By Therapeutic Area, 20162023 (USD Million)
Table 87 US: Market, By End User, 20162023 (USD Million)
Table 88 Canada: CRO Services Market, By Type, 20162023 (USD Million)
Table 89 Canada: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 90 Canada: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 91 Canada: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 92 Canada: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 93 Canada: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 94 Canada: Market, By Therapeutic Area, 20162023 (USD Million)
Table 95 Canada: Market, By End User, 20162023 (USD Million)
Table 96 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 vs 2014
Table 97 Europe: CRO Services Market, By Country, 20162023 (USD Million)
Table 98 Europe: Market, By Type, 20162023 (USD Million)
Table 99 Europe: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 100 Europe: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 101 Europe: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 102 Europe: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 103 Europe: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 104 Europe: Market, By Therapeutic Area, 20162023 (USD Million)
Table 105 Europe: Market, By End User, 20162023 (USD Million)
Table 106 Germany: CRO Services Market, By Type, 20162023 (USD Million)
Table 107 Germany: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 108 Germany: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 109 Germany: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 110 Germany: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 111 Germany: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 112 Germany: Market, By Therapeutic Area, 20162023 (USD Million)
Table 113 Germany: Market, By End User, 20162023 (USD Million)
Table 114 UK: Market, By Type, 20162023 (USD Million)
Table 115 UK: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 116 UK: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 117 UK: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 118 UK: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 119 UK: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 120 UK: CRO Services Market, By Therapeutic Area, 20162023 (USD Million)
Table 121 UK: Market, By End User, 20162023 (USD Million)
Table 122 France: Market, By Type, 20162023 (USD Million)
Table 123 France: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 124 France: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 125 France: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 126 France: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 127 France: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 128 France: CRO Services Market, By Therapeutic Area, 20162023 (USD Million)
Table 129 France: Market, By End User, 20162023 (USD Million)
Table 130 Clinical Trials in Italy (2013 vs 2014)
Table 131 Italy: Market, By Type, 20162023 (USD Million)
Table 132 Italy: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 133 Italy: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 134 Italy: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 135 Italy: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 136 Italy: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 137 Italy: Market, By Therapeutic Area, 20162023 (USD Million)
Table 138 Italy: Market, By End User, 20162023 (USD Million)
Table 139 Spain: CRO Services Market, By Type, 20162023 (USD Million)
Table 140 Spain: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 141 Spain: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 142 Spain: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 143 Spain: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 144 Spain: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 145 Spain: Market, By Therapeutic Area, 20162023 (USD Million)
Table 146 Spain: Market, By End User, 20162023 (USD Million)
Table 147 Pharmaceutical R&D Expenditure & Production in RoE Countries (2012 vs 2014)
Table 148 RoE: CRO Services Market, By Type, 20162023 (USD Million)
Table 149 RoE: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 150 RoE: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 151 RoE: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 152 RoE: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 153 RoE: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 154 RoE: Market, By Therapeutic Area, 20162023 (USD Million)
Table 155 RoE: Market, By End User, 20162023 (USD Million)
Table 156 Total Number of Clinical Trials in Asia Pacific, By Therapeutic Area, 2017
Table 157 Asia Pacific: CRO Services Market, By Country, 20162023 (USD Million)
Table 158 Asia Pacific: Market, By Type, 20162023 (USD Million)
Table 159 Asia Pacific: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 160 Asia Pacific: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 161 Asia Pacific: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 162 Asia Pacific: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 163 Asia Pacific: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 164 Asia Pacific: CRO Services Market, By Therapeutic Area, 20162023 (USD Million)
Table 165 Asia Pacific: Market, By End User, 20162023 (USD Million)
Table 166 Total Number of Clinical Trials in China, By Therapeutic Area, 2017
Table 167 China: Market, By Type, 20162023 (USD Million)
Table 168 China: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 169 China: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 170 China: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 171 China: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 172 China: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 173 China: Market, By Therapeutic Area, 20162023 (USD Million)
Table 174 China: Market, By End User, 20162023 (USD Million)
Table 175 Japan: CRO Services Market, By Type, 20162023 (USD Million)
Table 176 Japan: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 177 Japan: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 178 Japan: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 179 Japan: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 180 Japan: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 181 Japan: Market, By Therapeutic Area, 20162023 (USD Million)
Table 182 Japan: Market, By End User, 20162023 (USD Million)
Table 183 Total Number of Clinical Trials in India, By Therapeutic Area, 2017
Table 184 Increase in R&D Expenditure of Top 5 Indian Pharmaceutical Companies (2010 vs 2017)
Table 185 India: CRO Services Market, By Type, 20162023 (USD Million)
Table 186 India: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 187 India: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 188 India: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 189 India: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 190 India: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 191 India: Market, By Therapeutic Area, 20162023 (USD Million)
Table 192 India: Market, By End User, 20162023 (USD Million)
Table 193 Total Number of Clinical Trials in Australia, Singapore, & Malaysia, By Therapeutic Area, 2017
Table 194 RoAPAC: Market, By Type, 20162023 (USD Million)
Table 195 RoAPAC: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 196 RoAPAC: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 197 RoAPAC: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 198 RoAPAC: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 199 RoAPAC: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 200 RoAPAC: CRO Services Market, By Therapeutic Area, 20162023 (USD Million)
Table 201 RoAPAC: Market, By End User, 20162023 (USD Million)
Table 202 Total Number of Clinical Trials in Latin America, By Therapeutic Area, 2017
Table 203 Latin America: Market, By Type, 20162023 (USD Million)
Table 204 Latin America: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 205 Latin America: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 206 Latin America: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 207 Latin America: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 208 Latin America: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 209 Latin America: Market, By Therapeutic Area, 20162023 (USD Million)
Table 210 Latin America: Market, By End User, 20162023 (USD Million)
Table 211 Total Number of Clinical Trials in the Middle East and Africa, By Therapeutic Area, 2017
Table 212 Middle East and Africa: CRO Services Market, By Type, 20162023 (USD Million)
Table 213 Middle East and Africa: Early-Phase Development Services Market, By Type, 20162023 (USD Million)
Table 214 Middle East and Africa: Preclinical Services Market, By Type, 20162023 (USD Million)
Table 215 Middle East and Africa: Clinical Research Services Market, By Type, 20162023 (USD Million)
Table 216 Middle East and Africa: Laboratory Services Market, By Type, 20162023 (USD Million)
Table 217 Middle East and Africa: Analytical Testing Services Market, By Type, 20162023 (USD Million)
Table 218 Middle East and Africa: Market, By Therapeutic Area, 20162023 (USD Million)
Table 219 Middle East and Africa: Market, By End User, 20162023 (USD Million)
Table 220 Growth Strategy Matrix (20142017)
List of Figures (46 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 CRO Services Market, By Type, 2018 vs 2023 (USD Billion)
Figure 5 Market, By Therapeutic Area, 2018 vs 2023 (USD Billion)
Figure 6 Market, By End User, 2018 vs 2023 (USD Billion)
Figure 7 Geographic Snapshot: CRO Services Market
Figure 8 Growing R&D Expenditure and Increase in Number of Clinical Trials to Drive Market Growth During the Forecast Period
Figure 9 Phase Iii Segment Will Continue to Dominate APAC Clinical Research Services Market During the Forecast Period
Figure 10 The US Dominated the Market in 2017
Figure 11 North America to Dominate the Market During the Forecast Period
Figure 12 China to Register the Highest Growth During the Forecast Period
Figure 13 Contract Research Organization (CRO) Services Market: Drivers, Opportunities, and Challenges
Figure 14 Number of New Chemical Or Biological Entities (19972016)
Figure 15 Total Number of Registered Studies (20052017)
Figure 16 Total Number of New Molecular Entity (NME) and New Biologic License Application (BLA) Filings and Approvals in the US, 20062015
Figure 17 Key Trends in the CRO Services Market
Figure 18 Clinical Research Services Segment Will Continue to Dominate the Global Market By 2023
Figure 19 Comparative Analysis of Clinical Trials Over the Years (20102016)
Figure 20 Biopharmaceutical Drugs Under Development, By Therapeutic Area, 2016
Figure 21 Phases of Drug Discovery Studies
Figure 22 Oncology Segment Will Continue to Dominate the Global Market By 2023
Figure 23 Worldwide Cancer Incidence and Mortality (20122025)
Figure 24 Total Number of Clinical Trials for Oncology (2017)
Figure 25 Diabetes Prevalence, By Country, 2015 (Million Individuals)
Figure 26 Pharmaceutical & Biopharmaceutical Companies Segment to Dominate the CRO Services Market During the Forecast Period
Figure 27 R&D Spending of Phrma Member Companies, 19802015
Figure 28 Clinical Studies for Medical Devices (2017)
Figure 29 Market: Geographic Growth Opportunities
Figure 30 Total Number of Clinical Trials: Global vs North America (2017)
Figure 31 North America: Market Snapshot
Figure 32 Pharmaceutical R&D Expenditure in the US (19902014)
Figure 33 Europe: Market Snapshot
Figure 34 Asia Pacific: Market Snapshot
Figure 35 Key Developments in the Market, 20142017
Figure 36 Global Market Share, By Key Player, 2017
Figure 37 IQVIA: Company Snapshot
Figure 38 LabCorp: Company Snapshot
Figure 39 PAREXEL: Company Snapshot
Figure 40 PRA Health Sciences: Company Snapshot
Figure 41 ICON PLC: Company Snapshot
Figure 42 Inc Research Holdings: Company Snapshot
Figure 43 WuXi Pharmatech: Company Snapshot
Figure 44 Charles River: Company Snapshot (2016)
Figure 45 Medpace Holdings: Company Snapshot
Figure 46 SGS: Company Snapshot
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Contract Research Organization Services (CROs) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Contract Research Organization Services (CROs) Market